When compared to GLP1RAs, which improve insulin sensitivity primarily through weight reduction, a post-doc regression analysis of HOMA2-IR indicates that only 2030% of the improvement in insulin sensitization observed with tirzepatide is due to weight loss (NCT03951753) [77, 78]
Moulton, C
What to monitor Track the following metrics to assess whether the levocarnitine addition is providing value: Body composition changes (use DEXA, InBody, or similar if accessible) Energy levels and exercise performance GI symptoms (compare to baseline on tirzepatide alone if possible) Liver function markers (ALT, AST) if baseline values were elevated General well-being and recovery quality If after 8 to 12 weeks the levocarnitine addition has not produced noticeable improvements in energy, exercise performance, or body composition compared to tirzepatide alone, consider adjusting your protocol or switching to a different compound blend
Questions about safety during pregnancy, for children, or for specific medical conditions should only be answered by your doctor or pharmacist, who can review your health status and the product leaflet
Sometimes GLP-1s that are approved for type 2 diabetes can be prescribed off-label for weight loss
This success drove people to search for easier, cheaper alternativesenter GLP-1 patches. These adhesive products, marketed as Ozempic patches or weight loss patches, are dietary supplements sold via Amazon, brand websites, and influencer links